Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum

Complete tumour resection following secondary cytoreductive surgery is associated with improved survival in selected groups of patients with recurrent ovarian cancer. However, other clinical factors than surgical cytoreduction are of considerable significance in determining the outcome of the salvage treatment.